RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
JD Health of Guangzhou, the online health-care arm of China e-commerce giant JD.com, completed a $3.5 billion Hong Kong IPO and rose 56% in its first trading session. JD Health offers 30-minute delivery of pharmaceuticals, online access to doctors and health services such as genetic testing. It was spun out of JD.com last year. The company now has a $45 billion market capitalization. JD Health competes with TenCent’s WeDoctor and Alibaba’s AliHealth in the online health services space.
Source: China Biotoday